High-dose cyclophosphamide as salvage therapy for severe aplastic anemia
- 1 May 2004
- journal article
- clinical trial
- Published by Elsevier in Experimental Hematology
- Vol. 32 (5) , 435-440
- https://doi.org/10.1016/j.exphem.2004.02.002
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Late complications following treatment for severe aplastic anemia (SAA) with high-dose cyclophosphamide (Cy): follow-up of a randomized trialBlood, 2002
- High-dose cyclophosphamide for refractory autoimmune hemolytic anemiaBlood, 2002
- Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: The experience in four centersTransplantation and Cellular Therapy, 2001
- Current Results of Bone Marrow Transplantation in Patients with Acquired Severe Aplastic AnemiaActa Haematologica, 2000
- Rabbit antithymocyte globulin (r‐ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapyBritish Journal of Haematology, 1999
- Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapyTransplantation and Cellular Therapy, 1999
- Unrelated donor bone marrow transplantation for children and adolescents with aplastic anaemia or myelodysplasiaBritish Journal of Haematology, 1997
- Unrelated donor bone marrow transplantation to treat severe aplastic anaemia in children and young adultsBritish Journal of Haematology, 1996
- Late haematological complications in severe aplastic anaemiaBritish Journal of Haematology, 1988
- MARROW GRAFT REJECTION AND VENO-OCCLUSIVE DISEASE OF THE LIVER IN PATIENTS WITH APLASTIC ANEMIA CONDITIONED WITH CYCLOPHOSPHAMIDE AND CYCLOSPORINETransplantation, 1986